128 related articles for article (PubMed ID: 37565528)
1. Pharmacokinetic Modeling Using Real-World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement-Clinical Outcomes Relationship.
Salem AM; Smith T; Wilkes J; Bailly DK; Heyrend C; Profsky M; Yellepeddi VK; Gopalakrishnan M
J Clin Pharmacol; 2024 Jan; 64(1):30-44. PubMed ID: 37565528
[TBL] [Abstract][Full Text] [Related]
2. Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: A Pharmacokinetic-Pharmacodynamic Modeling Approach.
Salem AM; Niu T; Li C; Moffett BS; Ivaturi V; Gopalakrishnan M
J Clin Pharmacol; 2022 Jun; 62(6):733-746. PubMed ID: 34816442
[TBL] [Abstract][Full Text] [Related]
3. Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.
Al-Jazairi A; Raslan S; Al-Mehizia R; Dalaty HA; De Vol EB; Saad E; Alanazi M; Owaidah T
Ann Pharmacother; 2021 May; 55(5):592-604. PubMed ID: 32959678
[TBL] [Abstract][Full Text] [Related]
4. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
[TBL] [Abstract][Full Text] [Related]
5. Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels.
Schechter T; Finkelstein Y; Ali M; Kahr WH; Williams S; Chan AK; Deveber G; Brandão LR
J Thromb Haemost; 2012 Mar; 10(3):368-74. PubMed ID: 22244010
[TBL] [Abstract][Full Text] [Related]
6. Anti-Factor Xa-Based Anticoagulation during Extracorporeal Membrane Oxygenation: Potential Problems and Possible Solutions.
Ranucci M; Cotza M; Isgrò G; Carboni G; Ballotta A; Baryshnikova E;
Semin Thromb Hemost; 2020 Jun; 46(4):419-427. PubMed ID: 31563131
[TBL] [Abstract][Full Text] [Related]
7. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
[TBL] [Abstract][Full Text] [Related]
8. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
Dieplinger B; Egger M; Luft C; Hinterreiter F; Pernerstorfer T; Haltmayer M; Mueller T
J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
[TBL] [Abstract][Full Text] [Related]
9. Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation.
Hohlfelder B; Kelly D; Hoang M; Anger KE; Sylvester KW; Kaufman RM; Connors JM
Am J Ther; 2022 Jul; 29(4):e385-e393. PubMed ID: 31833874
[TBL] [Abstract][Full Text] [Related]
10. Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.
McMichael ABV; Hornik CP; Hupp SR; Gordon SE; Ozment CP
ASAIO J; 2020 Mar; 66(3):307-313. PubMed ID: 30883406
[TBL] [Abstract][Full Text] [Related]
11. Performance Assessment of Anti-Xa Assay-Based Heparin Dosing Protocol in Pediatric Patients on Extracorporeal Membrane Oxygenation.
Al-Jazairi AS; Shorog EM; Owaidah TM; Al Dalaty H; Alheriash YA; Almehizia RA; Alahmadi MD
World J Pediatr Congenit Heart Surg; 2023 Nov; 14(6):723-728. PubMed ID: 37654250
[TBL] [Abstract][Full Text] [Related]
12. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
[TBL] [Abstract][Full Text] [Related]
13. Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients.
Kulig CE; Schomer KJ; Black HB; Dager WE
ASAIO J; 2021 Apr; 67(4):411-415. PubMed ID: 33769995
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study.
Mayerhöfer T; Joannidis M; Peer A; Perschinka F; Fries D; Mair P; Gasteiger L; Bachler M; Kilo J; Herkner H; Schwameis M; Schellongowski P; Nagler B; Kornfehl A; Staudinger T; Buchtele N
Thromb Res; 2024 Apr; 236():161-166. PubMed ID: 38452448
[TBL] [Abstract][Full Text] [Related]
15. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants.
Pollak U
Perfusion; 2018 May; 33(1_suppl):7-17. PubMed ID: 29788841
[TBL] [Abstract][Full Text] [Related]
17. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study.
Irby K; Swearingen C; Byrnes J; Bryant J; Prodhan P; Fiser R
Pediatr Crit Care Med; 2014 May; 15(4):e175-82. PubMed ID: 24622165
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.
Tang S; Xu L; Li H; Wu Z; Wen Q
Eur J Clin Pharmacol; 2023 Dec; 79(12):1583-1594. PubMed ID: 37740749
[TBL] [Abstract][Full Text] [Related]
19. Unfractionated heparin dosing requirements in the presence of inflammation during the first six months of life.
Heizer JW; Schardt TQ; Murphy ME; Branchford BR
Thromb Res; 2019 May; 177():17-22. PubMed ID: 30844684
[TBL] [Abstract][Full Text] [Related]
20. Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation.
Prakash S; Wiersema UF; Bihari S; Roxby D
Anaesth Intensive Care; 2016 Jan; 44(1):85-92. PubMed ID: 26673593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
